Activation of cancer immunotherapy by nanomedicine
Cancer is one of the most difficult diseases to be treated in the world. Immunotherapy has made great strides in cancer treatment in recent years, and several tumor immunotherapy drugs have been approved by the U.S. Food and Drug Administration. Currently, immunotherapy faces many challenges, such a...
Saved in:
Main Authors: | Lijuan Wang (Author), Henan Xu (Author), Lili Weng (Author), Jin Sun (Author), Ye Jin (Author), Chunping Xiao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomedicine for Combination Urologic Cancer Immunotherapy
by: Yun Tian, et al.
Published: (2023) -
Light-responsive nanomedicine for cancer immunotherapy
by: Weirong Kang, et al.
Published: (2023) -
Cancer immunotherapy and its facilitation by nanomedicine
by: Chao Sui, et al.
Published: (2024) -
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
by: Yanyan Xu, et al.
Published: (2022) -
When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
by: Linna Yu, et al.
Published: (2022)